SEC Form 6-K Summary
Filing period: July 2021; filed July 30, 2021. The provided filing identifies the registrant as China Jo-Jo Drugstores, Inc. (CJJD), not Ridgetech Inc.; this company-name discrepancy should be verified.
Business Context and Corporate Event
CJJD completed a corporate reorganization and redomicile merger at 9:00 a.m. Eastern Time on July 30, 2021. China Jo-Jo Drugstores Holdings, Inc., a Cayman Islands company, became the publicly held parent of CJJD, with CJJD merging into and being absorbed by the Cayman entity.
- Each outstanding CJJD common share was converted into the right to receive one ordinary share of CJJD Cayman.
- Approximately 41,751,790 CJJD Cayman ordinary shares were issued in the merger.
- CJJD Cayman ordinary shares were approved for listing on Nasdaq Capital Market and began trading under the existing ticker symbol, CJJD, on July 30, 2021.
- The pre-reorganization directors and officers were appointed to the corresponding positions at CJJD Cayman.
- CJJD expects to file Form 15 to terminate registration of its former common stock and suspend its Exchange Act reporting obligations.
Financial Metrics and Capital Structure
The filing is primarily a corporate reorganization and capital-rights disclosure. It does not provide current or comparable-period revenue, profit, cash flow, margins, debt, cash, liquidity, or operating guidance. The filing text does not provide clear values for those metrics.
- CJJD Cayman is authorized to issue 500,000,000 shares with a par value of $0.001 per share.
- No preferred shares were outstanding immediately before the reorganization.
- The board may issue additional ordinary shares and establish preferred share classes without shareholder approval, subject to the governing documents and applicable law.
- Dividends may be paid only from legally available profits or share premium and only if the company can continue paying its debts as they become due.
Material Changes Versus the Prior Period
- The legal parent changed from a Nevada corporation to a Cayman Islands exempted company.
- Shareholder rights changed from those under Nevada law to those under the Cayman Islands Companies Act and CJJD Cayman’s amended and restated memorandum and articles of association.
- The successor issuer is deemed registered under Exchange Act Section 12(b) pursuant to Rule 12g-3.
- The operating business and the pre-reorganization management structure were not described as changing in this filing.
Outlook, Risks, and Unusual Items
No financial forecast or operating outlook is included. The principal unusual item is the completed redomicile merger.
- The board’s authority to issue preferred shares could create dilution, affect voting power, and be used as an anti-takeover measure.
- Cayman Islands corporate law and the amended articles govern shareholder rights after the transaction; these rights may differ materially from Nevada shareholder protections.
- Shareholders generally have no broad statutory right under Cayman Islands law to inspect corporate records or shareholder lists, although annual audited financial statements are expected to be provided.
- The filing states that the transfer agent and registrar is expected to be American Stock Transfer & Trust Company, LLC.
- The anticipated Form 15 filing and completion of the successor-issuer process should be confirmed.
Investor Verification Items
- Confirm that the filing belongs to China Jo-Jo Drugstores, Inc. rather than Ridgetech Inc.
- Verify the effectiveness of the merger, the one-for-one share conversion, and the approximately 41.75 million shares issued.
- Confirm Nasdaq listing and trading continuity under ticker CJJD.
- Review the Form F-4, prospectus, and amended and restated memorandum and articles for detailed shareholder-rights differences.
- Confirm whether CJJD filed Form 15 and whether the successor issuer’s ongoing SEC reporting obligations remain active.
- Obtain the company’s latest financial statements separately, because this 6-K does not report operating or financial performance.